About this Research Topic
Cardiovascular diseases represent a big health problem worldwide, both in terms of health costs and quality of life. For these reasons, the use of biomarkers appears the cheapest choice to screen and follow-up people with cardiovascular disease. The ideal biomarker should be widely available, cheap and reliable. In the last decades several biomarkers have been proposed and used with this purpose (i.e. CRP, uric acid, troponin, natriuretic peptides, etc) and several others are emerging ones (gamma-glutamyltransferase, miRNA, etc). The majority of these biomarkers are used to predict cardiovascular risk in specific settings of the population.
To our knowledge, none of the existing biomarkers for cardiovascular disease are routinely used and scientifically validated in all population settings and do not appear in cardiovascular risk scores. Thus, the aim of this Research Topic is to spread knowledge about useful novel biomarkers to predict and/or to manage cardiovascular risk, as well as to systematically analyze previously published literature in order to draw definitive conclusions about the use of specific biomarkers in the field of cardiovascular disease.
Topics suitable for submission include, but are not limited to:
1) Use of biomarkers in specific population settings.
2) Role of biomarkers in cardiovascular risk prediction.
3) Development of new cardiovascular risk score models.
4) Role of biomarkers in disease progression monitoring.
5) Role of biomarkers in therapeutic efficacy monitoring.
To our knowledge, none of the existing biomarkers for cardiovascular disease are routinely used and scientifically validated in all population settings and do not appear in cardiovascular risk scores. Thus, the aim of this Research Topic is to spread knowledge about useful novel biomarkers to predict and/or to manage cardiovascular risk, as well as to systematically analyze previously published literature in order to draw definitive conclusions about the use of specific biomarkers in the field of cardiovascular disease.
Topics suitable for submission include, but are not limited to:
1) Use of biomarkers in specific population settings.
2) Role of biomarkers in cardiovascular risk prediction.
3) Development of new cardiovascular risk score models.
4) Role of biomarkers in disease progression monitoring.
5) Role of biomarkers in therapeutic efficacy monitoring.
Keywords: biomarkers, cardiovascular disease, cardiovascular outcomes, follow-up, screening
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
